The 2018 Cholesterol Management Guidelines: Topics in Secondary ASCVD Prevention Clinicians Need to Know View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-06

AUTHORS

Xiaoming Jia, Mahmoud Al Rifai, Yochai Birnbaum, Sidney C. Smith, Salim S. Virani

ABSTRACT

PURPOSE OF REVIEW: The 2018 ACC/AHA Multisociety blood cholesterol guidelines provide updated recommendations based on contemporary evidence on the management of serum cholesterol for the prevention of atherosclerotic cardiovascular disease (ASCVD) events. This review discusses clinically important topics in the new guidelines related to secondary ASCVD prevention. RECENT FINDINGS: Since the 2013 ACC/AHA blood cholesterol guidelines, several large randomized control trials involving ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors (evolocumab and alirocumab) have been published. The trials provided evidence that these non-statin, LDL-cholesterol lowering agents are efficacious in reducing risk for ASCVD events in patients with clinical ASCVD. The 2018 guidelines incorporate these new findings into updated clinical recommendations on therapeutic strategies related to the use of ezetimibe and PCSK9 inhibitors. The guidelines also recommend risk stratification of secondary prevention patients to identify those at very high-risk of ASCVD events as these patients would derive the most absolute risk reduction from the addition of non-statin therapies. While high-intensity statins remain the first-line treatment to prevent recurrent ASCVD events in secondary prevention patients, ezetimibe and PCSK9 inhibitors are evidence-based non-statin agents that can be used when residual on top of maximally tolerated statin therapy in patients deemed to be at very-high risk of recurrent ASCVD events. More... »

PAGES

20

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11883-019-0784-8

DOI

http://dx.doi.org/10.1007/s11883-019-0784-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113179868

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30941517


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Baylor College of Medicine", 
          "id": "https://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jia", 
        "givenName": "Xiaoming", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Department of Medicine, University of Kansas School of Medicine, Wichita, KS, USA", 
            "Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Al Rifai", 
        "givenName": "Mahmoud", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baylor College of Medicine", 
          "id": "https://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Birnbaum", 
        "givenName": "Yochai", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of North Carolina at Chapel Hill", 
          "id": "https://www.grid.ac/institutes/grid.10698.36", 
          "name": [
            "Division of Cardiology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "Sidney C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Michael E. DeBakey VA Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.413890.7", 
          "name": [
            "Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA", 
            "Health Policy, Quality and Informatics Program, Health Services Research and Development Center for Innovations, Michael E. DeBakey Veterans Affairs Medical Center, 2002 Holcombe Boulevard, 77030, Houston, TX, USA", 
            "Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Virani", 
        "givenName": "Salim S.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1371/journal.pone.0169761", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001698977"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa061894", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002835057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0706201", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009092702"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jvs.2006.12.054", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012779373"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(16)31357-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022126083"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)61350-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028469827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2013.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031012810"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacl.2015.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031965516"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2004.07.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032203188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/030079902125000787", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032585997"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1410489", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037703611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2011.860", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042831011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14740338.4.3.389", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044116587"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14740338.4.3.389", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044116587"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehw272", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048191967"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000296277.63350.77", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064349905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000296277.63350.77", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064349905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000296277.63350.77", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064349905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2016.11.070", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083861623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1615664", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084149639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.117.028503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085311557"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.117.028503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085311557"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamacardio.2017.2289", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090951560"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.117.032235", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092675334"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.117.032235", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092675334"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.117.032235", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092675334"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2017.10.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092862920"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.atherosclerosis.2018.03.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101549813"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.atherosclerosis.2018.03.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101549813"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.118.034309", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103279892"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.118.034309", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103279892"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.117.032615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103854960"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.117.032615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103854960"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.117.032615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103854960"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/jaha.117.008426", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105411583"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1801174", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109762180"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2018.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109848980"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2018.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109848980"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2018.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109848980"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2018.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109848980"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/m18-1776", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111022485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/m18-1776", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111022485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/m18-1776", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111022485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(18)31942-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111821807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(18)31942-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111821807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(18)31942-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111821807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(18)31942-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111821807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(18)31942-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111821807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(18)31942-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111821807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(18)31942-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111821807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(18)31942-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111821807"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-06", 
    "datePublishedReg": "2019-06-01", 
    "description": "PURPOSE OF REVIEW: The 2018 ACC/AHA Multisociety blood cholesterol guidelines provide updated recommendations based on contemporary evidence on the management of serum cholesterol for the prevention of atherosclerotic cardiovascular disease (ASCVD) events. This review discusses clinically important topics in the new guidelines related to secondary ASCVD prevention.\nRECENT FINDINGS: Since the 2013 ACC/AHA blood cholesterol guidelines, several large randomized control trials involving ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors (evolocumab and alirocumab) have been published. The trials provided evidence that these non-statin, LDL-cholesterol lowering agents are efficacious in reducing risk for ASCVD events in patients with clinical ASCVD. The 2018 guidelines incorporate these new findings into updated clinical recommendations on therapeutic strategies related to the use of ezetimibe and PCSK9 inhibitors. The guidelines also recommend risk stratification of secondary prevention patients to identify those at very high-risk of ASCVD events as these patients would derive the most absolute risk reduction from the addition of non-statin therapies. While high-intensity statins remain the first-line treatment to prevent recurrent ASCVD events in secondary prevention patients, ezetimibe and PCSK9 inhibitors are evidence-based non-statin agents that can be used when residual on top of maximally tolerated statin therapy in patients deemed to be at very-high risk of recurrent ASCVD events.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11883-019-0784-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1021897", 
        "issn": [
          "1523-3804", 
          "1534-6242"
        ], 
        "name": "Current Atherosclerosis Reports", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "21"
      }
    ], 
    "name": "The 2018 Cholesterol Management Guidelines: Topics in Secondary ASCVD Prevention Clinicians Need to Know", 
    "pagination": "20", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11883-019-0784-8"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f251322356d992fd83dd70b42cc6a78d66ce406a3cabeac3f619be8c03ebddcb"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113179868"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100897685"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30941517"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11883-019-0784-8", 
      "https://app.dimensions.ai/details/publication/pub.1113179868"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-15T09:13", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000376_0000000376/records_56159_00000006.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs11883-019-0784-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11883-019-0784-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11883-019-0784-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11883-019-0784-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11883-019-0784-8'


 

This table displays all metadata directly associated to this object as RDF triples.

192 TRIPLES      21 PREDICATES      58 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11883-019-0784-8 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Ne761cd9ee67147d98c0bcddf725b7f4a
4 schema:citation https://doi.org/10.1001/jama.2011.860
5 https://doi.org/10.1001/jamacardio.2017.2289
6 https://doi.org/10.1016/j.atherosclerosis.2018.03.026
7 https://doi.org/10.1016/j.jacc.2004.07.001
8 https://doi.org/10.1016/j.jacc.2013.11.002
9 https://doi.org/10.1016/j.jacc.2016.11.070
10 https://doi.org/10.1016/j.jacc.2017.10.001
11 https://doi.org/10.1016/j.jacc.2018.11.002
12 https://doi.org/10.1016/j.jacl.2015.11.002
13 https://doi.org/10.1016/j.jvs.2006.12.054
14 https://doi.org/10.1016/s0140-6736(10)61350-5
15 https://doi.org/10.1016/s0140-6736(16)31357-5
16 https://doi.org/10.1016/s0140-6736(18)31942-1
17 https://doi.org/10.1056/nejmoa061894
18 https://doi.org/10.1056/nejmoa0706201
19 https://doi.org/10.1056/nejmoa1410489
20 https://doi.org/10.1056/nejmoa1615664
21 https://doi.org/10.1056/nejmoa1801174
22 https://doi.org/10.1093/eurheartj/ehw272
23 https://doi.org/10.1161/circulationaha.117.028503
24 https://doi.org/10.1161/circulationaha.117.032235
25 https://doi.org/10.1161/circulationaha.117.032615
26 https://doi.org/10.1161/circulationaha.118.034309
27 https://doi.org/10.1161/jaha.117.008426
28 https://doi.org/10.1185/030079902125000787
29 https://doi.org/10.1212/01.wnl.0000296277.63350.77
30 https://doi.org/10.1371/journal.pone.0169761
31 https://doi.org/10.1517/14740338.4.3.389
32 https://doi.org/10.7326/m18-1776
33 schema:datePublished 2019-06
34 schema:datePublishedReg 2019-06-01
35 schema:description PURPOSE OF REVIEW: The 2018 ACC/AHA Multisociety blood cholesterol guidelines provide updated recommendations based on contemporary evidence on the management of serum cholesterol for the prevention of atherosclerotic cardiovascular disease (ASCVD) events. This review discusses clinically important topics in the new guidelines related to secondary ASCVD prevention. RECENT FINDINGS: Since the 2013 ACC/AHA blood cholesterol guidelines, several large randomized control trials involving ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors (evolocumab and alirocumab) have been published. The trials provided evidence that these non-statin, LDL-cholesterol lowering agents are efficacious in reducing risk for ASCVD events in patients with clinical ASCVD. The 2018 guidelines incorporate these new findings into updated clinical recommendations on therapeutic strategies related to the use of ezetimibe and PCSK9 inhibitors. The guidelines also recommend risk stratification of secondary prevention patients to identify those at very high-risk of ASCVD events as these patients would derive the most absolute risk reduction from the addition of non-statin therapies. While high-intensity statins remain the first-line treatment to prevent recurrent ASCVD events in secondary prevention patients, ezetimibe and PCSK9 inhibitors are evidence-based non-statin agents that can be used when residual on top of maximally tolerated statin therapy in patients deemed to be at very-high risk of recurrent ASCVD events.
36 schema:genre research_article
37 schema:inLanguage en
38 schema:isAccessibleForFree false
39 schema:isPartOf N361af3feae454865afe9bb9cc4765de3
40 Ncf9bd28b7fde4a8c84ab996368c5581b
41 sg:journal.1021897
42 schema:name The 2018 Cholesterol Management Guidelines: Topics in Secondary ASCVD Prevention Clinicians Need to Know
43 schema:pagination 20
44 schema:productId N2661fad41301428f94e0a571daec904a
45 N7214074ebe0e43eeac3faf7f0f5951f0
46 N9cc9ec02f5a9438291b0770abaa6d639
47 Naced7eb886964228bc8786a55827c471
48 Nf8cab309bbfb40efb927d19e94a5054d
49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113179868
50 https://doi.org/10.1007/s11883-019-0784-8
51 schema:sdDatePublished 2019-04-15T09:13
52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
53 schema:sdPublisher N60ab04f154214ac7868e4086cdccf278
54 schema:url https://link.springer.com/10.1007%2Fs11883-019-0784-8
55 sgo:license sg:explorer/license/
56 sgo:sdDataset articles
57 rdf:type schema:ScholarlyArticle
58 N093001fa39b94c54ab4eb15e027cd958 schema:affiliation https://www.grid.ac/institutes/grid.10698.36
59 schema:familyName Smith
60 schema:givenName Sidney C.
61 rdf:type schema:Person
62 N10bc6f55a27f4f50a1dd25dedef412a9 schema:affiliation https://www.grid.ac/institutes/grid.39382.33
63 schema:familyName Jia
64 schema:givenName Xiaoming
65 rdf:type schema:Person
66 N2661fad41301428f94e0a571daec904a schema:name readcube_id
67 schema:value f251322356d992fd83dd70b42cc6a78d66ce406a3cabeac3f619be8c03ebddcb
68 rdf:type schema:PropertyValue
69 N361af3feae454865afe9bb9cc4765de3 schema:volumeNumber 21
70 rdf:type schema:PublicationVolume
71 N3f84196b62354ec081da6c5a9e316ccd schema:affiliation https://www.grid.ac/institutes/grid.413890.7
72 schema:familyName Virani
73 schema:givenName Salim S.
74 rdf:type schema:Person
75 N4a842fc8037f49b0b646ee93f58f2050 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
76 schema:familyName Al Rifai
77 schema:givenName Mahmoud
78 rdf:type schema:Person
79 N533da1a8a5d149a793626e7f2135c10c rdf:first N4a842fc8037f49b0b646ee93f58f2050
80 rdf:rest N7c08edb1fa954cf6b01a2479b3e839d7
81 N60ab04f154214ac7868e4086cdccf278 schema:name Springer Nature - SN SciGraph project
82 rdf:type schema:Organization
83 N7214074ebe0e43eeac3faf7f0f5951f0 schema:name nlm_unique_id
84 schema:value 100897685
85 rdf:type schema:PropertyValue
86 N7c08edb1fa954cf6b01a2479b3e839d7 rdf:first Nd3d6f0d57450418fb1dfa40268c827fb
87 rdf:rest Nd987e693206044df9a248cb5e2588a8b
88 N9cc9ec02f5a9438291b0770abaa6d639 schema:name doi
89 schema:value 10.1007/s11883-019-0784-8
90 rdf:type schema:PropertyValue
91 Naced7eb886964228bc8786a55827c471 schema:name dimensions_id
92 schema:value pub.1113179868
93 rdf:type schema:PropertyValue
94 Nc4c0f6ceae744a27bb41a11c5a70cbba rdf:first N3f84196b62354ec081da6c5a9e316ccd
95 rdf:rest rdf:nil
96 Ncf9bd28b7fde4a8c84ab996368c5581b schema:issueNumber 6
97 rdf:type schema:PublicationIssue
98 Nd3d6f0d57450418fb1dfa40268c827fb schema:affiliation https://www.grid.ac/institutes/grid.39382.33
99 schema:familyName Birnbaum
100 schema:givenName Yochai
101 rdf:type schema:Person
102 Nd987e693206044df9a248cb5e2588a8b rdf:first N093001fa39b94c54ab4eb15e027cd958
103 rdf:rest Nc4c0f6ceae744a27bb41a11c5a70cbba
104 Ne761cd9ee67147d98c0bcddf725b7f4a rdf:first N10bc6f55a27f4f50a1dd25dedef412a9
105 rdf:rest N533da1a8a5d149a793626e7f2135c10c
106 Nf8cab309bbfb40efb927d19e94a5054d schema:name pubmed_id
107 schema:value 30941517
108 rdf:type schema:PropertyValue
109 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
110 schema:name Medical and Health Sciences
111 rdf:type schema:DefinedTerm
112 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
113 schema:name Cardiorespiratory Medicine and Haematology
114 rdf:type schema:DefinedTerm
115 sg:journal.1021897 schema:issn 1523-3804
116 1534-6242
117 schema:name Current Atherosclerosis Reports
118 rdf:type schema:Periodical
119 https://doi.org/10.1001/jama.2011.860 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042831011
120 rdf:type schema:CreativeWork
121 https://doi.org/10.1001/jamacardio.2017.2289 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090951560
122 rdf:type schema:CreativeWork
123 https://doi.org/10.1016/j.atherosclerosis.2018.03.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101549813
124 rdf:type schema:CreativeWork
125 https://doi.org/10.1016/j.jacc.2004.07.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032203188
126 rdf:type schema:CreativeWork
127 https://doi.org/10.1016/j.jacc.2013.11.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031012810
128 rdf:type schema:CreativeWork
129 https://doi.org/10.1016/j.jacc.2016.11.070 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083861623
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1016/j.jacc.2017.10.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092862920
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1016/j.jacc.2018.11.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1109848980
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1016/j.jacl.2015.11.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031965516
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1016/j.jvs.2006.12.054 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012779373
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1016/s0140-6736(10)61350-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028469827
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1016/s0140-6736(16)31357-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022126083
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1016/s0140-6736(18)31942-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111821807
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1056/nejmoa061894 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002835057
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1056/nejmoa0706201 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009092702
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1056/nejmoa1410489 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037703611
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1056/nejmoa1615664 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084149639
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1056/nejmoa1801174 schema:sameAs https://app.dimensions.ai/details/publication/pub.1109762180
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1093/eurheartj/ehw272 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048191967
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1161/circulationaha.117.028503 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085311557
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1161/circulationaha.117.032235 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092675334
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1161/circulationaha.117.032615 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103854960
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1161/circulationaha.118.034309 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103279892
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1161/jaha.117.008426 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105411583
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1185/030079902125000787 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032585997
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1212/01.wnl.0000296277.63350.77 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064349905
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1371/journal.pone.0169761 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001698977
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1517/14740338.4.3.389 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044116587
174 rdf:type schema:CreativeWork
175 https://doi.org/10.7326/m18-1776 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111022485
176 rdf:type schema:CreativeWork
177 https://www.grid.ac/institutes/grid.10698.36 schema:alternateName University of North Carolina at Chapel Hill
178 schema:name Division of Cardiology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA
179 rdf:type schema:Organization
180 https://www.grid.ac/institutes/grid.21107.35 schema:alternateName Johns Hopkins University
181 schema:name Department of Medicine, University of Kansas School of Medicine, Wichita, KS, USA
182 Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA
183 rdf:type schema:Organization
184 https://www.grid.ac/institutes/grid.39382.33 schema:alternateName Baylor College of Medicine
185 schema:name Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
186 Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
187 rdf:type schema:Organization
188 https://www.grid.ac/institutes/grid.413890.7 schema:alternateName Michael E. DeBakey VA Medical Center
189 schema:name Health Policy, Quality and Informatics Program, Health Services Research and Development Center for Innovations, Michael E. DeBakey Veterans Affairs Medical Center, 2002 Holcombe Boulevard, 77030, Houston, TX, USA
190 Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA
191 Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
192 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...